Anti-Egfr×Anti-Fap Bi-Specific Targeting Antibody Combined with Irinotecan Encapsulated Liposomes for Pancreatic Cancer Therapy(2/3)

Project: A - Government Institution › b - National Science and Technology Council

Project Details

StatusFinished
Effective start/end date8/1/19 → 7/31/20

Keywords

  • pancreatic cancer
  • liposomal drug
  • targeted liposome
  • bi-specific antibody

Access Project